Estropipate 雌酮硫酸酯哌嗪
CAS 7280-37-7 MFCD00867399
化学结构图
SMILES: C1CNCCN1.C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)O)cc4CC[C@H]3[C@@H]1CCC2=O
化学属性
| Mol. Formula | C22H32O5N2S |
|---|---|
| Mol. Weight | 437 |
别名和识别编码
| Chemical Name | Estropipate |
|---|---|
| Synonym | 3,5(10)-trien-17-one,3-(sulfooxy)-estra-compd.withpiperazine(1:1) 3-(Sulfooxy)-estra-1,3,5(10)-trien-17-one : piperazine (1:1) 3-(Sulfooxy)-estra-1,3,5(10)-trien-17-one : piperazine (1:1) Estrone sulfate piperazine salt Estropipate Harmogen Ogen Estra-1,3,5(10)-trien-17-one 3-sulphate piperazine (1:1) Estrone sulfate piperazine salt Estrone sulphate piperazine Genoral Harmogen Harmonet Ogen Ortho-Est PIPERAZINEESTRONESULPHATE PIPERAZINEOESTRONESULPHATE Piperazine estrone sulfate Sulestrex estra-1,3,5(10)-trien-17-one 3-sulphate, compound with piperazine (1:1) estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1) estrone sulfate piperazine salt estrone,hydrogensulfate,compd.withpiperazine(1:1) estropipate {Pu |
| MDL Number | MFCD00867399 |
| CAS Number | 7280-37-7 |
| EC Number | 230-696-3 |
| Chemical Name Translation | 雌酮硫酸酯哌嗪 |
| LabNetwork Molecule ID | LN01343032 |
| PubChem Substance ID | 5284555 |
| InChI | InChI=1S/C18H22O5S.C4H10N2/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19;1-2-6-4-3-5-1/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22);5-6H,1-4H2/t14-,15-,16+,18+;/m1./s1 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Approved Therapeutics/Drug Candidates, Cell Biology, Cell Signaling and Neuroscience, Cytokines, Growth Factors and Hormones, Estrogen, Hormones, Johnson & Johnson, Steroid Hormones
- {SNA} Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Cytokines, Growth Factors and Hormones, E,
相关文献及参考
- Gui C, Obaidat A, Chaguturu R, Hagenbuch B., Development of a cell-based high-throughput assay to screen for inhibitors of organic anion transporting polypeptides Curr. Chem. Genomics 4 , 1-8, (2010) 摘要
- Egnell AC, Eriksson C, Albertson N, Houston B, Boyer S., Generation and evaluation of a CYP2C9 heteroactivation pharmacophore. J. Pharmacol. Exp. Ther. 3rd ed., 307 , 878-87, (2003) 摘要
- Poller L, Thomson JM, Coope J., A double-blind cross-over study of piperazine oestrone sulphate and placebo with coagulation studies. Br. J. Obstet. Gynaecol. 8th ed., 87 , 718-25, (1980) 摘要
安全信息
GHS Symbol
- P201 Obtain special instructions before use. 使用前获取专门指示。
- P202 Do not handle until all safety precautions have been read and understood. 已阅读并理解所有的安全预防措施之前，切勿操作。
- P260 Do not breathe dust/fume/gas/mist/vapours/spray. 不要吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
- P263 Avoid contact during pregnancy/while nursing. 怀孕/哺乳期间避免接触。
- P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
- P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西，喝水或吸烟。
- P281 Use personal protective equipment as required. 使用所需的个人防护装备。
- P301+P312
- P308+P313
- P330 Rinse mouth. 漱口
- P405 Store locked up. 上锁保管。
- P501 Dispose of contents/container to..… 处理内容物/容器.....
- H302 Harmful if swallowed 吞食有害
- H350 May cause cancer 可能致癌
- H351 Suspected of causing cancer 怀疑致癌
- H360 May damage fertility or the unborn child 可能对生育能力或未出生婴儿造成伤害
- H362 May cause harm to breast-fed children 可能对母乳喂养的婴儿造成伤害
- S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时，立即求医（可能时出示标签）；
- S53 Avoid exposure - obtain special instructions before use 避免接触，使用前获得特别指示说明；
- R45 May cause cancer 可能致癌
- R22 Harmful if swallowed 吞咽有害
其他信息
- MOL 文件:7280-37-7.mol
京ICP备2020036287号